Cardiovascular and microvascular outcomes of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled cardiovascular outcome trials with trial sequential analysis

Randomized Controlled ◽

Glucagon Like Peptide ◽

CARDIOVASCULAR BENEFIT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN FEMALE PATIENTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF RECENT CARDIOVASCULAR OUTCOME TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(19)30847-2 ◽

2019 ◽

Vol 73 (9) ◽

pp. 239

Author(s):

David Aguilar ◽

Efstratios Koutroumpakis ◽

Heinrich Taegtmeyer

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Cardiovascular Benefit

Comparative safety of glucagon like peptide‑1 receptor agonists in patients with type 2 diabetes: a network meta-analysis of cardiovascular outcome trials

10.37766/inplasy2020.8.0122 ◽

2020 ◽

Author(s):

Chuanjun Zhuo ◽

Hongjun Tian ◽

Lina Wang ◽

Xiangyang Gao ◽

Li Ding ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Comparative Safety

Abstract P077: Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Outcomes in Black Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Recent Cardiovascular Outcome Trials

Circulation ◽

10.1161/circ.139.suppl_1.p077 ◽

2019 ◽

Vol 139 (Suppl_1) ◽

Author(s):

Efstratios Koutroumpakis ◽

Heinrich Taegtmeyer ◽

David Aguilar

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Black Patients ◽

Glucagon Like Peptide ◽

Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials

Scientific Reports ◽

10.1038/s41598-017-16018-9 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 4

Author(s):

Fang Zhang ◽

Lizhi Tang ◽

Yuwei Zhang ◽

Qingguo Lü ◽

Nanwei Tong

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Diabetes Patients

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.06.009 ◽

2019 ◽

Vol 154 ◽

pp. 101-115 ◽

Cited By ~ 5

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Lorenzo Scappaticcio ◽

Miriam Longo ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon-Like Peptide-1 Receptor Agonists in Adult Patients With Type 2 Diabetes: Review of Cardiovascular Outcome Trials

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.08.011 ◽

2020 ◽

Vol 44 (1) ◽

pp. 68-77 ◽

Cited By ~ 4

Author(s):

Elodie M. Varin ◽

Brent A. McLean ◽

Julie A. Lovshin

Keyword(s):

Type 2 Diabetes ◽

Adult Patients ◽

Cardiovascular Outcome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials

Acta Diabetologica ◽

10.1007/s00592-017-1049-z ◽

2017 ◽

Vol 54 (11) ◽

pp. 1069-1071

Author(s):

Ilaria Dicembrini ◽

Besmir Nreu ◽

Alessia Scatena ◽

Francesco Andreozzi ◽

Giorgio Sesti ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon-like peptide-1 receptor agonists versus insulin glargine for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Current Therapeutic Research ◽

10.1016/j.curtheres.2010.08.003 ◽

2010 ◽

Vol 71 (4) ◽

pp. 211-238 ◽

Cited By ~ 20

Author(s):

Wei-Xin Li ◽

Jian-Feng Gou ◽

Jin-Hui Tian ◽

Xiang Yan ◽

Lin Yang

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials

Minerva Endocrinology ◽

10.23736/s0391-1977.20.03219-8 ◽

2020 ◽

Author(s):

Besmir Nreu ◽

Ilaria Dicembrini ◽

Federico Tinti ◽

Edoardo Mannucci ◽

Matteo Monami

Keyword(s):

Type 2 Diabetes ◽

Pancreatic Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Diabetes Care ◽

10.2337/dc16-1957 ◽

2017 ◽

Vol 40 (4) ◽

pp. 614-624 ◽

Cited By ~ 52

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Annalisa Capuano ◽

Katherine Esposito ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽